| 12202836 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Mark Edward Bunnage, Seungil Han, Frank Eldridge Lovering +18 more |
2025-01-21 |
|
| 12103921 |
Chemical compounds |
Ariamala Gopalsamy, Shawn Cabral, Agustin Casimiro Garcia, Ming Zhu Chen, Chulho Choi +10 more |
2024-10-01 |
$338,444,000 |
| 11702405 |
Chemical compounds |
Ariamala Gopalsamy, Shawn Cabral, Agustin Casimiro-Garcia, Ming Zhu Chen, Chulho Choi +10 more |
2023-07-18 |
$390,606,000 |
| 11702424 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Mark Edward Bunnage, Seungil Han, Frank Eldridge Lovering +18 more |
2023-07-18 |
$390,606,000 |
| 11014908 |
Chemical compounds |
Ariamala Gopalsamy, Arjun Venkat Narayanan, Agustin Casimiro-Garcia, Chulho Choi, David W. Piotrowski +10 more |
2021-05-25 |
$425,301,000 |
| 10906888 |
Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme |
Agustin Casimiro-Garcia, Joseph Walter Strohbach, Frank Eldridge Lovering, Chulho Choi, Christophe Philippe Allais +1 more |
2021-02-02 |
$640,415,000 |
| 10793579 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Mark Edward Bunnage, Seungil Han, Frank Eldridge Lovering +18 more |
2020-10-06 |
$629,973,000 |
| 10329302 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Mark Edward Bunnage, Seungil Han, Frank Eldridge Lovering +18 more |
2019-06-25 |
$317,230,000 |
| 10316018 |
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators |
Katherine Lin Lee, Christophe Philippe Allais, Christoph Martin Dehnhardt, Lori Krim Gavrin, Seungil Han +10 more |
2019-06-11 |
$297,650,000 |
| 10174000 |
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators |
Katherine Lin Lee, Christophe Philippe Allais, Christoph Martin Dehnhardt, Lori Krim Gavrin, Seungil Han +10 more |
2019-01-08 |
$262,548,000 |
| 9879022 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Mark Edward Bunnage, Seungil Han, Frank Eldridge Lovering +18 more |
2018-01-30 |
$267,454,000 |
| 9873673 |
2-thiopyrimidinones |
Philip A. Carpino, Edward L. Conn, Robert L. Dow, Matthew S. Dowling, Daniel Wei-Shung Kung +6 more |
2018-01-23 |
$117,720,000 |
| 9458168 |
Bicyclic-fused heteroaryl or aryl compounds |
John David Trzupek, Katherine Lin Lee, Mark Edward Bunnage, Seungil Han, Frank Eldridge Lovering +15 more |
2016-10-04 |
$808,860,000 |
| 9440949 |
Diacylglycerol acyltransferase 2 inhibitors |
Shawn Cabral, Kentaro Futatsugi, Kim Huard, Daniel Wei-Shung Kung, Suvi Tuula Marjukka Orr +1 more |
2016-09-13 |
$277,429,000 |
| 9399626 |
2-thiopyrimidinones |
Philip A. Carpino, Edward L. Conn, Robert L. Dow, Matthew S. Dowling, Daniel Wei-Shung Kung +6 more |
2016-07-26 |
$447,864,000 |
| 9296745 |
Diacylglycerol acyltransferase 2 inhibitors |
Kay Ahn, Markus Boehm, Shawn Cabral, Philip A. Carpino, Kentaro Futatsugi +3 more |
2016-03-29 |
$310,571,000 |
| 8841314 |
2-Thiopyrimidinones |
Roger B. Ruggeri |
2014-09-23 |
$606,941,000 |
| 8835449 |
2-thiopyrimidinones |
Edward L. Conn, Roger B. Ruggeri |
2014-09-16 |
$606,980,000 |
| 7902188 |
Morpholine dopamine agonists |
Charlotte Moira Norfor Allerton, Andrew Douglas Baxter, Andrew Cook, Stephen Kwok-Fung Wong |
2011-03-08 |
$212,034,000 |
| 7649002 |
(3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists |
Andrew Antony Calabrese, David Fradet, Mark Ian Lansdell |
2010-01-19 |
$279,046,000 |
| 7576081 |
Morpholine dopamine agonists |
Charlotte Moira Norfor Allerton, Andrew Douglas Baxter, Andrew Cook, Stephen Kwok-Fung Wong |
2009-08-18 |
$206,216,000 |
| 7323462 |
Morpholine dopamine agonists |
Charlotte Moira Norfor Allerton, Andrew Douglas Baxter, Andrew Cook, Stephen Kwok-Fung Wong |
2008-01-29 |
$150,264,000 |
| 7129234 |
Phenyl heterocyclyl ethers |
Mavis Adam, Mark Andrews, Geoffrey E. Gymer, Harry Howard, Donald Middleton +1 more |
2006-10-31 |
$291,859,000 |
| 6914160 |
Oxytocin inhibitors |
Duncan Robert Armour, Andrew Simon Bell, Paul Edwards, David Ellis, Mark Llewellyn Lewis +1 more |
2005-07-05 |
$351,280,000 |
| 6800652 |
Diaryl compounds |
Mark Andrews, Donald Middleton |
2004-10-05 |
$392,072,000 |
